Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

SEC Filings

SEC Filings

Form Description Filing date View
FWP

FWP

View HTML
FWP

FWP

View HTML
FWP

FWP

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

View HTML
CERTNAS

CERTNAS

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML

Copyright Morningstar



Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved